Beyond Air Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and WarrantsGlobe Newswire • about 1 month ago
GARDEN CITY, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ( Beyond Air or the Company ), a commercial stage medical device and biopharmaceutical company focused on...
Share to Feed
Beyond Air, Inc. (NASDAQ:XAIR Get Free Report) was the target of a significant increase in short interest in January. As of January 31st, there was short interest totalling 3,150,000 shares...
Beyond Air (NASDAQ:XAIR Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.50) EPS for the quarter, beating analysts consensus estimates of...
Commercial demand for LungFit PH increasing; manufacturing of upgraded devices is ramping up to meet growing demand PMA supplement for the expansion of LungFit PH label to include cardiac surgery...
Call scheduled for Monday, February 12th at 4:30 pm Eastern TimeGARDEN CITY, N.Y., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ( Beyond Air or the Company ), a commercial...
Beyond Air, Inc. (NASDAQ:XAIR Get Free Report) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling...